Award
NIH Reporter #5F30CA278322-03
Anti-Complement Immunotherapy for Pancreatic Cancer
Recipient
Albert Einstein College of Medicine, Bronx, NY, United States
Award Amount
$55,114.00
Ceiling
$55,114.00
Awarded
January 07, 2026
Identifier
5F30CA278322-03
The award supports research on the role of complement activation in pancreatic cancer and the development of immunotherapy strategies combining complement blockade and radiotherapy.
Description
This project aims to understand how complement activation in the tumor microenvironment promotes oncogenesis in pancreatic ductal adenocarcinoma (PDAC) and to explore translational therapeutics that blockade complement signaling, alone and in combination with radiotherapy, as potential immunotherapeutic strategies for PDAC.